MedPath

Management of Perioperative Pain Using Erector Spinae Plane Block in Open Microscopic Lumbar Surgery

Not Applicable
Recruiting
Conditions
Lumbar Spine Disease
Interventions
Procedure: Skin infiltration LA
Procedure: Erector spinae plane block
Registration Number
NCT06270654
Lead Sponsor
University of Malaya
Brief Summary

The aim of this study is to compare patients receiving bilateral erector spinae block with ropivacaine vs control group in terms of pain score, total opioid consumption, hemodynamic changes intraoperatively, length of hospitalisation , time to ambulation post surgery and quality of recovery.

Detailed Description

Most open spine surgery exacts a high degree of postsurgical pain due to the incision and muscle dissection of the vertebra. The postoperative pain control and early mobilization improve the quality of the surgical care. Inadequate pain relief might result in perioperative morbidity, resulting in prolonged hospital stays.

Erector spinae plane block (ESPB) is an interfascial plane block where local anaesthetic is injected in a plane preferably below the erector spinae muscle. It can provide thoracic, abdominal, and even some lower extremity analgesia. It was also theorised that erector spinae plane block can reduce opioid use and provide analgesia for lumbar surgery. The financial cost that is saved by reducing the length of hospital stay, perioperative morbidity will warrant the use of erector spinae plane block in patients undergoing lumbar spine surgery.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age 18-75
  • Patients with Glasgow Coma Scale of 15.
  • American Society of Anaesthesiologists (ASA) Physical Status Classification I - II patients
  • Scheduled for elective, open microscopic lumbar surgery (less than 3 levels) under general anesthesia.
Read More
Exclusion Criteria
  • Cognitive impairment
  • Patient refusal
  • Weight<50kg, >120kg
  • Allergy to local anesthesia
  • Alcohol/ drug abuse
  • Renal failure or liver failure
  • Coagulopathy/thrombocytopenia
  • Chronic pain with chronic opioid usage
  • Ischemic heart disease
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupSkin infiltration LAPre incision of 0.375% ropivacaine 10ml local infiltration will be given.
Ropivacaine groupErector spinae plane blockBilateral erector spinae plane block (0.375% 20ml ropivacaine on each side + adrenaline 1:200,000) pre incision.
Primary Outcome Measures
NameTimeMethod
Pain score at recovery, 30mins, 1, 2, 4, 8,12, 24 hours post-surgery24 hours

Measure by numerical rating scale (minimum 1-least pain, maximum 10-most painful)

Total opioid consumption intraoperative48 hours

Measure by total dose consumed (in milligram)

Total opioid consumption post-operativeup to 72 hours

Measure by total dose consumed (in milligram)

Timing of first rescue dose of iv morphineup to 24 hours

Post operation till time requiring first dose of iv morphine

Secondary Outcome Measures
NameTimeMethod
The quality of recovery score (QoR)-15 questionnaire at 24 hours post-operation24 hours

Measure by the quality of recovery score (QoR)-15 questionnaire (minimum of 0,maximum of 150,higher score means a better outcome)

Length of hospital staysup to 1 week

Days of stay in hospital

Time to ambulation after surgeryup to 1 week

Time from operation till ambulation

Hemodynamic changes intraoperativeIntraoperative period

heart rate (heart rate measure via heart beats per minute/ECG)

Trial Locations

Locations (1)

Universiti Malaya Medical Centre

🇲🇾

Kuala Lumpur, Wilayah Persekutuan, Malaysia

© Copyright 2025. All Rights Reserved by MedPath